113 related articles for article (PubMed ID: 6986982)
1. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM
Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982
[No Abstract] [Full Text] [Related]
2. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
Wirth PJ; Thorgeirsson SS
Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
[No Abstract] [Full Text] [Related]
3. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
Hinson JA; Andrews LS; Gillette JR
Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
[No Abstract] [Full Text] [Related]
4. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
[TBL] [Abstract][Full Text] [Related]
5. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
Kaneda S; Seno T; Takeishi K
J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
[TBL] [Abstract][Full Text] [Related]
6. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
[No Abstract] [Full Text] [Related]
7. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation.
Vaught JB; McGarvey PB; Lee MS; Garner CD; Wang CY; Linsmaier-Bednar EM; King CM
Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926
[TBL] [Abstract][Full Text] [Related]
8. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
[TBL] [Abstract][Full Text] [Related]
9. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
Stout DL; Baptist JN; Matney TS; Shaw CR
Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
[TBL] [Abstract][Full Text] [Related]
10. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
Beranek DT; White GL; Heflich RH; Beland FA
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
[TBL] [Abstract][Full Text] [Related]
11. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
Kurelec B; Krca S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
Stout DL; Becker FF
Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
[No Abstract] [Full Text] [Related]
14. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
McGregor D
Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
Schut HA; Thorgeirsson SS
Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
[No Abstract] [Full Text] [Related]
16. Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
Marhevka VC; Ebner NA; Sehon RD; Hanna PE
J Med Chem; 1985 Jan; 28(1):18-24. PubMed ID: 3965709
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
Smith TJ; Hanna PE
Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
[TBL] [Abstract][Full Text] [Related]
18. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
Castro CE; Felkner IC; Yang SP
Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
[No Abstract] [Full Text] [Related]
19. Metabolic activation of 2-acetylaminofluorene.
Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
[No Abstract] [Full Text] [Related]
20. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
Razzouk C; Batardy-Grégoire M; Roberfroid M
Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
